PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals Inc's cash flow from others for the three months ended in Sep. 2016 was $0.59 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2016 was $1.68 Mil.
Progenics Pharmaceuticals Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2016 was 0.569 (Dec. 2015 ) + 0.084 (Mar. 2016 ) + 0.429 (Jun. 2016 ) + 0.594 (Sep. 2016 ) = $1.68 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Progenics Pharmaceuticals Inc Annual Data
|Cash Flow from Others||25.99||-0.45||0.97||0.98||-0.01||0.00||-0.33||0.92||3.99||1.60|
Progenics Pharmaceuticals Inc Quarterly Data
|Cash Flow from Others||0.29||0.80||1.45||0.30||0.79||-0.18||0.57||0.08||0.43||0.59|